Bohui 3+11 High-Performance Hpv Nucleic Acid Detection Solution

Name: Bohui 3+11 High-Performance Hpv Nucleic Acid Detection Solution
Brand: Beijing Bohui Innovation Biotechnology Group Co., Ltd
SKU: 2282684905

Beijing, ChinaBeijing Bohui Innovation Biotechnology Group Co., Ltd

US$1.25-1.75

1 Test

Product profile

Customization

Available

Type

IVD Reagent

Sensitivity (Lod)

10 Copies/Reaction

Model NO.

HR-HPV 3+11

Platform

Ma-6000 Real-Time Quantitativethermal Cycler Slan-

Throughput

96 Samples Per Run

Time to Result

2.5h /Run

Sample Type

Cervical Swabs

Transport Package

Box

Specification

24T/Kit

Trademark

BOHUI

Origin

China

Key features

Comprehensive HPV Detection: Detects 14 high-risk HPV types including 16, 18, and 52 genotyping in a single reaction.

High Sensitivity: Limit of detection is 10 copies per reaction for accurate results.

Internal Quality Control: Incorporates beta-globin to ensure nucleic acid extraction and amplification quality.

Anti-Contamination Design: Equipped with UNG/dUTP system to guarantee detection accuracy.

Excellent Repeatability: Coefficient of variation is less than 5.0% across 10 replicates.

Fast Turnaround Time: Results available in 2.5 hours per run.

High Throughput: Processes 96 samples per run on compatible platforms.

Flexible Customization: Offers full, minor, and sample-based customization options.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceExperienced TeamSelf-branded

Beijing Bohui Innovation Biotechnology Group Co., Ltd

Beijing, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 year CertifiedNearest Port: Tianjin PortAverage Response Time: ≤7.31h

AI-Powered supplier vetting

SummaryBohui Group is a Beijing-based high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. It reports CE and other product certifications, ISO9001:2015, ISO45001:2018, and ISO14001 management certifications. The supplier maintains documented procedures and records for corrective actions, complaint handling, supplier approval, and service assessment. It reports recent new-product activity and broad customization options, but does not provide 3D software design services. Service reach is limited: no overseas agents, branches, warehouses, or showrooms are reported, although the supplier has participated in WHX Labs Dubai 2026 and identifies Tianjin Port as its nearest port. Inventory capability and stated lead times within 15 workdays are reported. Manufacturing capacity is not supported by a valid contract with its affiliated subcontractor. Financial credibility cannot be determined from the provided financial information, and no customer cases are explicitly identified.

Supplier typeThe supplier is described as a combined company and a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. Its stated business scope covers technical development and sales of medical devices, medical analysis instruments, and related equipment.

CertificationsThe supplier reports CE and other product compliance certifications, plus ISO9001:2015, ISO45001:2018, ISO14001, and other management-system certifications. It also reports an environmental impact assessment report, providing explicit evidence of certification and environmental documentation.

After-Sales capabilityDocumented procedures and followed records exist for corrective and preventive actions, customer complaints, supplier approval, and service-capability assessment. However, the supplier reports no overseas agents or branches, overseas warehouse, or overseas showroom; it does report inventory capability, participation in WHX Labs Dubai 2026, and lead times within 15 workdays.

R&D capabilityThe company operates a 40,000 square-meter R&D center and reports R&D capability with new products introduced during the past year. Its business scope also includes technical development of medical devices and analytical instruments.

Production capacityThe supplier reports in-stock capability and order fulfillment within 15 workdays during both peak and off-season periods. However, it explicitly lacks a valid manufacturing-capacity contract with its factory and affiliated subcontractor, so production capacity is not fully secured by the provided evidence.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. It does not provide 3D software design services, but the stated customization coverage is broad.